Maguire, Michael <br/><br/>
Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Mar 2002 
 - 731-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.46.3.731-738.2002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carbamates<br/>Cloning, Molecular<br/>Drug Resistance, Microbial<br/>Drug Therapy, Combination<br/>Furans<br/>Genotype<br/>HIV Core Protein p24--drug effects<br/>HIV Infections--drug therapy<br/>HIV Protease--genetics<br/>HIV Protease Inhibitors--therapeutic use<br/>HIV Reverse Transcriptase--antagonists & inhibitors<br/>HIV-1--drug effects<br/>Humans<br/>Mutagenesis, Site-Directed<br/>Nucleosides--pharmacology<br/>Phenotype<br/>RNA, Viral--chemistry<br/>Reverse Transcriptase Inhibitors--therapeutic use<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Sulfonamides--therapeutic use